Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kirk

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Palliative Care|November 7, 2002
A needs assessment for southern Manitoba physicians for palliative care educationCheryl Barnabé, Peter Kirk
Immunity|October 18, 2005
Pathogen recognition: TLRs throw us a curvePeter Kirk, J Fernando Bazan
Journal of Deaf Studies and Deaf Education|March 20, 2025
Deaf adult insights into elements of classroom discourse altered in interpretationPeter Kirk Crume, Elizabeth Caldwell Langer
Journal of Deaf Studies and Deaf Education|December 10, 2024
Deaf adult insights into elements of classroom discourse altered in interpretationPeter Kirk Crume, Elizabeth Caldwell Langer
BMJ (Clinical Research Ed.)|May 21, 2004
What do patients receiving palliative care for cancer and their families want to be told? A Canadian and Australian qualitative studyPeter Kirk, Ingrid Kirk, Linda J Kristjanson
Patient Education and Counseling|October 13, 2009
An experimental investigation of the dilemma of delivering bad newsAgustín Del Vento, Janet Bavelas, Sara Healing, et al.
The New Zealand Medical Journal|June 25, 2013
Palliative care patients' use of emergency departmentsRoss Lawrenson, James Waetford, Veronique Gibbons, et al.
BMC Biochemistry|November 11, 2003
A novel form of the membrane protein CD147 that contains an extra Ig-like domain and interacts homophilicallyS Melanie Hanna, Peter Kirk, Oliver J Holt, et al.
Urology|September 1, 2018
Population Analysis of Male Urethral Stricture Management and Urethroplasty Success in the United StatesCooper R Benson, Robert Goldfarb, Peter Kirk, et al.
Plos One|July 6, 2017
Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapyDeborah Charych, Samira Khalili, Vidula Dixit, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Palliative Care|November 7, 2002
A needs assessment for southern Manitoba physicians for palliative care educationCheryl Barnabé, Peter Kirk
Immunity|October 18, 2005
Pathogen recognition: TLRs throw us a curvePeter Kirk, J Fernando Bazan
Journal of Deaf Studies and Deaf Education|March 20, 2025
Deaf adult insights into elements of classroom discourse altered in interpretationPeter Kirk Crume, Elizabeth Caldwell Langer
Journal of Deaf Studies and Deaf Education|December 10, 2024
Deaf adult insights into elements of classroom discourse altered in interpretationPeter Kirk Crume, Elizabeth Caldwell Langer
BMJ (Clinical Research Ed.)|May 21, 2004
What do patients receiving palliative care for cancer and their families want to be told? A Canadian and Australian qualitative studyPeter Kirk, Ingrid Kirk, Linda J Kristjanson
Patient Education and Counseling|October 13, 2009
An experimental investigation of the dilemma of delivering bad newsAgustín Del Vento, Janet Bavelas, Sara Healing, et al.
The New Zealand Medical Journal|June 25, 2013
Palliative care patients' use of emergency departmentsRoss Lawrenson, James Waetford, Veronique Gibbons, et al.
BMC Biochemistry|November 11, 2003
A novel form of the membrane protein CD147 that contains an extra Ig-like domain and interacts homophilicallyS Melanie Hanna, Peter Kirk, Oliver J Holt, et al.
Urology|September 1, 2018
Population Analysis of Male Urethral Stricture Management and Urethroplasty Success in the United StatesCooper R Benson, Robert Goldfarb, Peter Kirk, et al.
Plos One|July 6, 2017
Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapyDeborah Charych, Samira Khalili, Vidula Dixit, et al.
Pageof 2